Chemogenomic profiling of breast cancer patient-derived xenografts reveals targetable vulnerabilities for difficult-to-treat tumorsPaul Savage, Morag Park, Daniel Lai et al.|Communications Biology|2020Cited by 56
Abstract 2184: Defining cancer initiating cells and their vulnerabilities in renal cell carcinoma.Zohreh Mehrjoo, Y. Riazalhosseini, Hellen Kuasne et al.|Cancer Research|2026Cited by 0